Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants.

El Hag A, Nabil N, El Masry R, Awad EE, Mahmoud Fouda E, Bashir Hamed M, Abou Talib Y, Law A, Mendes D, Aladdin M

DOI: 10.1080/21645515.2026.2704277
Published: 2026 Dec
Container: Human vaccines & immunotherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2704277,
  title = {Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants.},
  author = {El Hag A and Nabil N and El Masry R and Awad EE and Mahmoud Fouda E and Bashir Hamed M and Abou Talib Y and Law A and Mendes D and Aladdin M},
  year = {2026},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2026.2704277},
  url = {https://doi.org/10.1080/21645515.2026.2704277}
}

RIS

TY  - JOUR
TI  - Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants.
AU  - El Hag A
AU  - Nabil N
AU  - El Masry R
AU  - Awad EE
AU  - Mahmoud Fouda E
AU  - Bashir Hamed M
AU  - Abou Talib Y
AU  - Law A
AU  - Mendes D
AU  - Aladdin M
PY  - 2026
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2026.2704277
UR  - https://doi.org/10.1080/21645515.2026.2704277
ER  -

APA

A, E. H., N, N., R, E. M., EE, A., E, M. F., M, B. H., Y, A. T., A, L., D, M., & M, A. (2026). Budget impact analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccination for preventing respiratory syncytial virus in Egyptian infants.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2026.2704277

Source records

pubmed · retrieved 2026-09-26T20:00:52.617Z